NOMURA FINANCIAL PRODUCTS EUROPE GMBH
Location
MILANO
Founded
2018-12-12
Website
Risk Signals
877 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Miscellaneous business Credit Institutions), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about NOMURA FINANCIAL PRODUCTS EUROPE GMBH
Live alerts from global media, monitored by Business Radar
2025-04-11 (financialexpress.com)
Q4FY25 Preview: Auto sector to post a subdued quarter; analysts say domestic players better positioned given global risks - Industry News | The Financial Express
Analysts expect downgrades across auto sector players due to global and domestic demand weakness. Nomura maintained that domestic players appear better positioned given global risks while volume growth is expected to remain modest across segments.
Read more2025-02-19 (ndtvprofit.com)
Stock Recommendations Today: Tata Motors, Venus Pipes, Macrotech Developers On Brokerages' Radar
Tata Motors Ltd., Venus Pipes Ltd., and Macrotech Developers Ltd. are among the top companies on brokerages' radar on Wednesday. Chemicals, information technology, and quick service restaurants are among the sectors analysts have done a deep dive into. Meanwhile, Nomura Research said that it remains underweight on emerging market Asia, barring overweight on Indonesia and Korea.
Read more2025-02-17 (businessupturn.com)
Brokerages cut target price for Samvardhana Motherson shares after Q3 results |
Samvardhana Motherson reported a weaker-than-expected Q3 performance, prompting both Nomura and JPMorgan to cut their target prices for the stock. Nomura downgraded its target to ₹155 from ₹209, while JPMorgan lowered its target to ₹160 from ₹190, citing near-term uncertainties in the global auto market. Nomura highlighted that while the company's acquisitions and ramp-up in […]
Read more2025-02-13 (milanofinanza.it)
South Korea sanctions JP Morgan, UBS, Morgan Stanley and Nomura. They are accused of illegal uncovered sales | MilanFinance News
In South Korea from November 2023 the practice of sale to the open of titles is illegal: criticized and then prohibited for having caused excessive volatility in the market. The prohibition should end in March
Read more2025-02-13 (marketscreener.com)
South Korea's Market Watchdog Imposes Fines On Jpmorgan, Nomura,… -February 13, 2025 at 12:00 am EST |
SOUTH KOREA'S MARKET WATCHDOG IMPOSES FINES ON JPMORGAN, NOMURA, UBS, MORGAN STANLEY FOR STOCK SHORT SELLING VIOLATIONS -OFFICIAL ...
Read more2025-02-11 (finversia.ru)
Wheel intelligence: BYD transforms autonomous driving using Deepseek - publications - Finversia (Finversion)
The shares of the Chinese car manufacturer BYD reached a record maximum after the company introduced a new system for assistance to the driver with artificial intelligence Deepseek.
Read more2025-02-10 (businessupturn.com)
Nomura on Fortis Health: Buy call, target at Rs 700, sees 8% upside on strong hospital revenue |
Nomura has maintained a buy rating on Fortis Healthcare, with a target price of ₹700 per share, indicating an upside potential of approximately 8% from its current market price (CMP) of ₹646. The brokerage highlighted that overall revenue was 2% above estimates, driven by hospital revenue, which came in 3% higher than expected, while the […]
Read more2025-01-30 (businessupturn.com)
Nomura maintains 'Neutral' on Maruti Suzuki stock, sees 11.2% upside amid strong exports but domestic demand concerns |
Nomura has retained its ‘Neutral’ rating on Maruti Suzuki, revising its target price to ₹13,290, indicating a 11.2% upside from the current market price of ₹11,953. The brokerage noted that Maruti’s Q3 FY25 performance was steady, with EBITDA margins aligning with consensus at 11.6%, slightly above Nomura’s estimate of 11.3% but marginally below the street’s […]
Read more2025-01-29 (businessupturn.com)
Nomura maintains 'Buy' on Cipla, sees 25% upside despite US launch delays |
Nomura has reiterated its Buy rating on Cipla, setting a target price of ₹1,780 per share, implying a 25% upside from the current market price of ₹1,427.00. The company’s Q3 earnings came in ahead of estimates, reflecting strong operational performance. However, delays in key US drug launches have impacted FY26 estimates, though FY27 projections remain […]
Read more2025-01-26 (worldarchitecture.org)
of. 1 Takatsuki TY Flighted two aircraft with the L -L -Law Competition Father Sound
World Architecture Community News - No.1 Takatsuki city Tonda 2 Ki Model House Competition
Read more2025-01-23 (businessupturn.com)
Brokerage Alert: Nomura maintains 'Neutral' on Persistent Systems, sees resilient growth |
Nomura brokerage has reiterated a 'Neutral' rating on Persistent Systems with a target price of ₹6,200, implying an upside potential of 9.6% from the current market price of ₹5,655.00.The brokerage emphasized resilient growth driven by strong executi
Read more2025-01-21 (businessupturn.com)
Nomura on ICICI Prudential: Retains 'Reduce,' cuts target price to Rs 715 amid subdued VNB margins |
Nomura has maintained its ‘Reduce’ rating on ICICI Prudential Life Insurance and revised the target price downward to ₹715 from ₹735. The updated target price implies a potential upside of 12.5% from the current market price (CMP) of ₹635.90. The brokerage highlighted strong growth in Annualized Premium Equivalent (APE), which has been largely attributed to […]
Read more